Integrative learning in developing an immunologic lncRNA signature as a consensus risk-stratification tool for lung adenocarcinoma

BACKGROUND: In the tumor immune microenvironment, the contribution of innate and adaptive immune cells to tumor progression has been consistently demonstrated. However, reliable prognostic biomarkers for lung adenocarcinoma (LUAD) have not yet been identified. We thus developed and validated an immu...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Zijian, Liu, Yangqi, Wan, Changhong, Huang, Weizhe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183502/
https://www.ncbi.nlm.nih.gov/pubmed/37197549
http://dx.doi.org/10.21037/jtd-23-372

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183502/
https://www.ncbi.nlm.nih.gov/pubmed/37197549
http://dx.doi.org/10.21037/jtd-23-372

Ejemplares similares